What Effect Does Radiotherapy Have on Healthy Brain Tissue?
Limitations identified in past evaluations of radiation-induced damage

Complete the form below to unlock access to ALL audio articles.
Radiotherapy (RT) plays a significant role in curative and palliative management of primary and secondary brain tumors.1 However, the unfortunate side effect is that healthy tissue is irradiated alongside the tumor, leading to brain tissue damage and cognitive impairment.
In fact, around 50–90% of brain tumor patients that survive at least 6 months after RT experience some form of cognitive decline, such as memory loss.2 Recently, in our systematic review conducted at the University of Manchester and published in the journal Neuro-Oncology Advances, we examined damage to the normal brain tissue after brain irradiation.3
Limitations identified in past evaluations of radiation-induced damage
We aimed to shed light on the factors that influence the magnitude of damage to the normal neurovascular unit (NVU) – the parts of the brain that regulate cerebral blood flow, enabling nutrient delivery to activated neurons – following irradiation and to determine when changes of the vasculature and neural tissue occur.
It is assumed that vascular damage after brain irradiation could contribute to cognitive dysfunction, thus efforts have been made by different groups to examine the impact of radiation on the blood–brain barrier (BBB) – the vascular component of the NVU – or the wider NVU (i.e. the vascular and neural tissue compartments).4–10 When Hart et al. (2022) systematically analyzed studies published before April 2020, they found that in both clinical and pre-clinical studies, brain irradiation increased BBB permeability at acute, delayed and late-delayed timepoints, 11 indicating that vascular changes can occur and exist long-term. Since they only focused on the effects of low linear energy transfer (LET) photons on the vascular component, we decided to conduct a systematic review to reveal the impact of various ionizing radiation (IR) types on the entire NVU.
Damage extent varies with radiation dose, dose rate and delivery technique
Recognizing the need for a wider analysis of the impact of IR on normal brain tissue, we analyzed the outputs from 6,883 studies using PubMed and Web of Science databases.
The review was conducted in accordance with the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines,12 and the studies that met the inclusion criteria (n = 82) were classified and quantitatively analyzed.
Our key findings were:
- Brain irradiation causes widespread effects on all components that make up the NVU, i.e. the endothelial cell layer, pericytes, astrocytes, microglia, extracellular matrix, neurons and oligodendrocytes.
- Damage is more severe with higher doses, low LET radiation, broader beams, lower dose rates and in tumor-bearing animal models.
- Changes in the vasculature and neural compartments occur at acute (up to one-month post-IR in preclinical and clinic settings), delayed (one-to-three months post-IR in preclinical or one-to-six months post-RT in clinic) and late (≥ three months post-IR in preclinical or ≥ six months post-RT in clinic)8,10,13 time windows.
IR-related chronic vascular changes could contribute to cognitive decline
Damage extent is more severe with low LET radiation, higher doses, lower dose rates and with broader beams. As expected, most studies concluded that higher doses result in more severe damage to the entire NVU and that damage appears faster than when lower doses are used. There were few comparable studies that investigated other factors, such as fractionation, high/low LET, tumor presence in the model irradiated and dose rate.
Another key finding is that changes or damage to both the vasculature and neural tissue can occur at acute, delayed and late time windows after irradiation. Even though the neural tissue is the central element for maintaining proper cognition,14 these findings indicate that the chronic changes in the vasculature could contribute to cognitive decline, which normally occurs as a late side effect.
Our work has provided a detailed overview of various changes that occur in the vasculature and neural compartments of the normal tissue after brain irradiation, when they occur and some key factors that determine damage severity.
We also identified crucial gaps in the field that need to be addressed or considered in future studies to increase relatability to clinical settings. These gaps relate to radiation (i.e. type, dose, source, dose rate and delivery method), animal models (tumor-bearing compared to non-tumor-bearing), techniques employed to examine changes and the timelines chosen.
Our findings were, however, limited by the majority of the studies being rodent models (89%) that used whole or partial brain irradiation at large, single doses. This differs from the therapeutic management of brain tumors in the clinic and does not reveal the differences in management of different patients (age, tumor location, tumor size etc.).
Moreover, the predominant model used was non-tumor-bearing rodents; out of the 69 in vivo studies, 61 used healthy (non-tumor-bearing) subjects. This limits our understanding of how the tumor impacts normal tissue toxicity, and how the tumor's presence may interact with cognition.
Equally important, this review focused on studies that used RT only, yet in clinical settings, it is often given as a combination with chemotherapy, surgery and immunotherapy. Despite providing detailed non-confounded effects of IR on the NVU of the normal brain tissue, they show an incomplete picture in relation to clinical outcomes.
Real-world clinical application
Since cognitive dysfunction has been reported in the presence 15–17 or absence of tumors 18–20 and before or after RT treatment,21–24 studies that compare IR effects and behavioral outcomes in tumor-bearing and naïve models are needed to address clearly how normal tissue toxicities drive long-term neurocognitive changes, independent of the tumor.
Also, future studies that combine RT with novel imaging, such as magnetic resonance imaging (MRI) would help to reveal NVU changes in real time,25 which can provide a broader understanding of when the normal tissue and cognitive changes occur.
Reference: Nakkazi A, Forster D, Whitfield GA, Dyer DP, Dickie BR. A systematic review of normal tissue neurovascular unit damage following brain irradiation-factors affecting damage severity and timing of effects. Neurooncol Adv. 2024; 6(1):vdae098. doi:10.1093/noajnl/vdae098
1. Burnet NG, Thomas SJ, Burton KE, Jefferies SJ. Defining the tumour and target volumes for radiotherapy. Cancer Imaging. 2004; 4(2):153-161. doi:10.1102/1470-7330.2004.0054
2. Armstrong CL, Shera DM, Lustig RA, Phillips PC. Phase measurement of cognitive impairment specific to radiotherapy. Int J Radiat Oncol Biol Phys. 2012; 83(3):e319-324. doi:10.1016/j.ijrobp.2011.12.083
3. Nakkazi A, Forster D, Whitfield GA, Dyer DP, Dickie BR. A systematic review of normal tissue neurovascular unit damage following brain irradiation-Factors affecting damage severity and timing of effects. Neurooncol Adv. 2024; 6(1):vdae098. doi:10.1093/noajnl/vdae098
4. Clemente CD, Holst EA. Pathological changes in neurons, neuroglia, and blood-brain barrier induced by x-irradiation of heads of monkeys. AMA Arch Neurol Psychiatry. 1954; 71(1):66-79. doi:10.1001/archneurpsyc.1954.02320370068005
5. Qin DX, Zheng R, Tang J, Li JX, Hu YH. Influence of radiation on the blood-brain barrier and optimum time of chemotherapy. Int J Radiat Oncol Biol Phys. 1990; 19(6):1507-1510. doi:10.1016/0360-3016(90)90364-p
6. Coderre J, Rubin P, Freedman A, et al. Selective ablation of rat brain tumors by boron neutron capture therapy. Int J Radiat Oncol Biol Phys. 1994; 28(5):1067-1077. doi:10.1016/0360-3016(94)90480-4
7. Fike JR, Gobbel GT, Chou D, et al. Cellular proliferation and infiltration following interstitial irradiation of normal dog brain is altered by an inhibitor of polyamine synthesis. Int J Radiat Oncol Biol Phys. 1995; 32(4):1035-1045. doi:10.1016/0360-3016(95)00030-3
8. Kamiryo T, Kassell NF, Thai QA, Lopes MB, Lee KS, Steiner L. Histological changes in the normal rat brain after gamma irradiation. Acta Neurochir (Wien). 1996; 138(4):451-459. doi:10.1007/BF01420308
9. Serduc R, Vérant P, Vial JC, et al. In vivo two-photon microscopy study of short-term effects of microbeam irradiation on normal mouse brain microvasculature. Int J Radiat Oncol Biol Phys. 2006; 64(5):1519-1527. doi:10.1016/j.ijrobp.2005.11.047
10. Ricard C, Fernández M, Gastaldo J, et al. Short-term effects of synchrotron irradiation on vasculature and tissue in healthy mouse brain. J Synchrotron Radiat. 2009; 16(Pt 4):477-483. doi:10.1107/S0909049509015428
11. Hart E, Odé Z, Derieppe MPP, et al. Blood-brain barrier permeability following conventional photon radiotherapy - A systematic review and meta-analysis of clinical and preclinical studies. Clin Transl Radiat Oncol. 2022; 35:44-55. doi:10.1016/j.ctro.2022.04.013
12. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62(10):e1-34. doi:10.1016/j.jclinepi.2009.06.006
13. Sheline GE, Wara WM, Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980; 6(9):1215-1228. doi:10.1016/0360-3016(80)90175-3
14. Galakhova AA, Hunt S, Wilbers R, et al. Evolution of cortical neurons supporting human cognition. Trends Cogn Sci. 2022; 26(11):909-922. doi:10.1016/j.tics.2022.08.012
15. Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: A comparative study. Lancet. 2002; 360(9343):1361-1368. doi:10.1016/s0140-6736(02)11398-5
16. Pospisil P, Kazda T, Hynkova L, et al. Post-WBRT cognitive impairment and hippocampal neuronal depletion measured by in vivo metabolic MR spectroscopy: Results of prospective investigational study. Radiother Oncol. 2017; 122(3):373-379. doi:10.1016/j.radonc.2016.12.013
17. Chu C, Davis CM, Lan X, et al. Neuroinflammation after stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease. Int J Radiat Oncol Biol Phys. 2020; 108(3):745-757. doi:10.1016/j.ijrobp.2020.05.027
18. Raber J, Rola R, LeFevour A, et al. Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis. Radiat Res. 2004; 162(1):39-47. doi:10.1667/rr3206
19. Ji S, Tian Y, Lu Y, et al. Irradiation-induced hippocampal neurogenesis impairment is associated with epigenetic regulation of bdnf gene transcription. Brain Res. 2014; 1577:77-88. doi:10.1016/j.brainres.2014.06.035
20. Parente A, Maciel ES, RA JOD, Langendijk JA, de Vries EFJ, Doorduin J. Delayed effects of a single-dose whole-brain radiation therapy on glucose metabolism and myelin density: a longitudinal PET study. Int J Radiat Biol. 2020; 96(9):1135-1143. doi:10.1080/09553002.2020.1787542
21. Tucha O, Smely C, Preier M, Lange KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery. 2000; 47(2):324-333; discussion 333-324. doi:10.1097/00006123-200008000-00011
22. Klein M, Taphoorn MJ, Heimans JJ, et al. Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001; 19(20):4037-4047. doi:10.1200/JCO.2001.19.20.4037
23. Meyers CA, Smith JA, Bezjak A, et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004; 22(1):157-165. doi:10.1200/JCO.2004.05.128
24. Chan A, Cheng I, Wang C, et al. Cognitive impairment in adolescent and young adult cancer patients: Pre-treatment findings of a longitudinal study. Cancer Med. 2023; 12(4):4821-4831. doi:10.1002/cam4.5295
25. Dickie BR, Boutin H, Parker GJM, Parkes LM. Alzheimer's disease pathology is associated with earlier alterations to blood-brain barrier water permeability compared with healthy ageing in TgF344-AD rats. NMR Biomed. 2021; 34(7):e4510. doi:10.1002/nbm.4510